Staff Volunteer

The petitioner proposes to continue research on developing advanced metabolomics and multiomics tools to comprehensively characterize the gut microbiome. This work focuses on creating pioneering live biotherapeutic drugs to target infections caused by antimicrobial-resistant bacteria.

The petitioner proposes to continue her research in biomedical science, specifically focusing on advancing the understanding of mechanisms behind deadly diseases such as cholera, Salmonella, and COVID-19. Her work involves characterizing complex factors in antibiotic production and resistance to accelerate the development of novel, therapeutically effective antibiotics. The research aims to mitigate the threat of bacterial infections and minimize the prevalence and mortality of infectious diseases in the United States.

The petitioner proposes to design and develop novel antimicrobial compounds for in vitro and in vivo applications to combat resistant pathogens and bridge the gap between basic discovery and clinical translation.

The petitioner proposes to explore microbial diversity and the production of bioactive compounds in harsh ecological conditions such as high salinity, extreme pH, or elevated temperatures. This research aims to identify new antibiotics and industrial enzymes to address increasing antibiotic resistance and the need for sustainable, biologically based industrial processes. He will continue to isolate, analyze, and characterize novel microbial strains for applications in medicine, agriculture, and environmental engineering.